Esperion Therapeutics Inc (ESPR)
Operating Cash Flow Growth
-22.51%
Quarterly · Period ending:
ESPR Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.51%period ending
Latest reported-22.51%period ending
ESPR Quarterly Cash from Operations YoY % (-28.51% → -22.51%)
Year-over-year change
High-resolution chart · PNG
ESPR operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -22.5119% | |
| 229.4432% | |
| 87.8669% | |
| -336.1138% | |
| -142.0376% | |
| 5.6779% | |
| -82.7943% | |
| 70.8889% | |
| 199.0286% | |
| 12.2997% | |
| 55.1124% | |
| 51.0211% | |
| -39.4101% | |
| 26.7788% | |
| 37.7582% | |
| -5.5697% | |
| 56.2245% | |
| 15.8191% | |
| 20.1936% | |
| -134.3394% | |
| -28.4381% | |
| -37.1165% | |
| -49.3581% | |
| 358.0885% | |
| -175.6312% | |
| -74.2437% | |
| -54.6327% | |
| -37.7851% | |
| 312.1446% | |
| 17.7267% | |
| -4.5786% | |
| -49.451% | |
| -25.95% | |
| -113.7411% | |
| -150.8669% | |
| -258.9435% | |
| -250.0561% | |
| -93.1116% | |
| -20.9129% | |
| 15.173% | |
| -5.8296% | |
| -2.9362% | |
| -37.0641% | |
| -41.7243% | |
| -1.7465% | |
| -8.9989% | |
| -80.6822% | |
| -91.1594% | |
| -246.6117% | |
| -217.7625% | |
| -64.3712% | |
| -11.6769% | |
| 2.1946% | |
| -7.1503% | |
| 13.0888% | |
| 3.9129% | |
| 6.944% | |
| -27.4304% | |
| -19.8221% | |
| -28.6879% | |
| -5.0853% | |
| -57.8219% | |
| -29.9508% | |
| -28.5147% |